Fliban 100 mg contains flibanserin, a medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It affects brain chemicals like dopamine and serotonin to help improve sexual desire. However, Fliban 100 mg is not recommended for patients with severe liver disease due to the way the drug is processed in the body.
Flibanserin is primarily metabolized in the liver. In patients with severe liver impairment, the liver cannot effectively break down the drug, leading to higher concentrations in the bloodstream. This increases the risk of serious side effects, such as severe low blood pressure (hypotension), fainting (syncope), and drowsiness.
Clinical studies have shown that FLIBAN 100 MG exposure can increase by up to 4.5 times in individuals with liver dysfunction. This can make side effects more intense and potentially dangerous. Because of this, the FDA has issued a strong warning against its use in patients with any degree of liver impairment.
In summary, Fliban 100 mg is contraindicated in patients with severe liver disease due to the inability to safely metabolize the drug, which can result in serious health risks. Always consult your doctor before starting any new medication, especially with liver-related conditions.
Add your comment